Extracorporeal Photopheresis as Treatment Option of Chronic Lung Allograft Dysfunction. Is ECP the Therapy of the Future?

被引：0
|
作者：
Benazzo, A. [1 ]
Landl, M. [1 ]
Mockenhuber, M. [1 ]
Schwarz, S. [1 ]
Murakoezy, G. O. [1 ]
Lambers, C. O. [1 ]
Moser, B. [1 ]
Hoetzenecker, K. [1 ]
Siguenza, J. O. Matilla [1 ]
Lang, G. O. [1 ]
Taghavi, S. [1 ]
Klepetko, W. [1 ]
Jaksch, P. [1 ]
机构：
[1] Med Univ Vienna, Thorac Surg, Vienna, Austria
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
260
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [21] Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)
    FJ Child
    R Ratnavel
    P Watkins
    D Samson
    J Apperley
    J Ball
    P Taylor
    R Russell-Jones
    Bone Marrow Transplantation, 1999, 23 : 881 - 887
  • [22] Extracorporeal Photopheresis (ECP) in Kidney Allograft Recipients: 1-Year Followup
    Kusztal, M.
    Koscielska-Kasprzak, K.
    Gdowska, W.
    Zabinska, M.
    Myszka, M.
    Klak, R.
    Krajewska, M.
    Boratynska, M.
    Szyber, P.
    Chudoba, P.
    Patrzalek, D.
    Klinger, M.
    TRANSPLANTATION, 2012, 94 (10) : 901 - 901
  • [23] Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction
    Hage, Chadi A.
    Klesney-Tait, Julia
    Wille, Keith
    Arcasoy, Selim
    Yung, Gordon
    Hertz, Marshall
    Chan, Kevin M.
    Morrell, Matt
    Goldberg, Hilary
    Vedantham, Suresh
    Derfler, Mary Clare
    Commean, Paul
    Berman, Keith
    Spitznagel, Ed
    Atkinson, Jeff
    Despotis, George
    TRANSFUSION MEDICINE, 2021, 31 (04) : 292 - 302
  • [24] Extracorporeal photopheresis -: successful treatment option for scleromyxedema?
    Durani, BK
    Bock, M
    Näher, H
    HAUTARZT, 2001, 52 : 938 - 941
  • [25] BUDGET IMPACT OF EXTRACORPOREAL PHOTOPHERESIS FOR TREATMENT OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION FOLLOWING LUNG TRANSPLANTATION IN SWITZERLAND RESULTS OF A SINGLE-CENTER RETROSPECTIVE CHART REVIEW
    Vogelmann, T.
    Gautschi, F.
    Ortmanns, G.
    Knoerr, F.
    Steinack, C.
    Hage, R.
    Schuurmans, M.
    VALUE IN HEALTH, 2022, 25 (12) : S124 - S125
  • [26] Extracorporeal photopheresis (ECP) in children with refractory chronic GVHD: Feasibility and efficacy
    Browning, B
    Collins, J
    Thormann, K
    Duerst, R
    Kletzel, M
    Jacobson, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 110 - 111
  • [27] EFFECTS OF EXTRACORPOREAL PHOTOPHERESIS (ECP) ON ELISPOT AND DENDRITIC CELLS PHENOTYPE IN KIDNEY ALLOGRAFT RECIPIENTS
    Kusztal, Mariusz
    KosCielska-Kasprzak, Katarzyna
    Zabinska, Marcelina
    Myszka, Marta
    Krajewska, Magdalena
    BoratynSka, Maria
    Chudoba, Pawel
    Lepiesza, Agniesza
    Klinger, Marian
    TRANSPLANT INTERNATIONAL, 2015, 28 : 159 - 160
  • [28] Local Intragraft Humoral Immune Response in Chronic Lung Allograft Dysfunction.
    Miyamoto, E.
    Juvet, S. C.
    Vosoughi, D.
    Wang, J.
    Al-Refaee, J.
    Daigneault, T.
    Duong, A.
    Moshkelgosha, S.
    Keshavjee, S.
    Tinckam, K.
    Chruscinski, A.
    Hwang, D.
    Martinu, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 996 - 996
  • [29] EXTRACORPOREAL PHOTOPHERESIS (ECP) IS AN EFFECTIVE THERAPY FOR THE TREATMENT OF CHILDREN WITH STEROID REFRACTORY (SR) CHRONIC GRAFT VS HOST DISEASE (cGVHD)
    Thormann, K.
    Collins, J.
    Jacobsohn, D. A.
    Rademaker, A.
    Duerst, R.
    Schneiderman, J.
    Tse, W.
    Kletzel, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 74 - 75
  • [30] Efficacy and Safety if JAK2 Inhibitor Plus Extracorporeal Photopheresis in Chronic Lung Allograft Dysfunction: A Single Centre Experience
    Negigowda, M.
    Rahulan, V.
    Lalani, M.
    Tisekar, O.
    Priyaranjan, S.
    Dutta, P.
    Mohandas, A.
    Sameer, M.
    Attawar, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S134 - S134
12345